Earlier this month, medical-device maker Datascope warned investors that it would delay the filing of its most recent quarterly results while it investigates several reports called into its ethics hotline, including a series of charges against its founder, chairman, and chief executive officer, Lawrence Saper.
Among other troubles the company listed in its regulatory filing: “The members of the internal audit department, legal department and chief financial officer alleged that the matters in question evidenced overrides of controls.”
